CSI Market
Sign In | Register

Core Laboratories Inc (CLB) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CLB quarterly Cash Flow →
Cash flow patterns shown here provide context for understanding Core Laboratories Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income30.39
Depreciation & amortization14.65
Amortization of Other Assets0.00
Increase (Decrease) in Insurance Assets-1.94
Asset Impairment Charges0.03
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase4.91
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation7.14
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions0.00
Gains (Losses) on Extinguishment of Debt0.00
Net Recovery Provision for Doubtful Accounts-
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest3.42
Impairments Inventory Write Down And Other Charges-3.78
Increase Decrease In Contract With Customer Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-4.95
Increase (Decrease) in Accounts Payable0.48
Accrued Expense-2.37
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.25
Other Working Capital-5.03
Other Noncash Income (Expense)0.68
Other net0.00
Payments for (Proceeds from) Other Operating Activities-6.83
Discontinued operations0.00
Net Cash flow from Operating Activities37.03
Investing Activities
Capital Expenditures-11.21
Sale of Capital Items3.02
Payments for (Proceeds from) Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Escrow Deposit Disbursements Related To Property Acquisition-0.15
Escrow Deposit Disbursements Related To Property Acquisition9.95
Payments Proceeds From Patents And Other Intangibles0.78
Proceeds From Sale Of Discontinued Operations-
Proceeds From Non Life Insurance Policies-
Premiums On Life Insurance Policies-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Insurance Settlement, Investing Activities0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-1.24
Interest in Subsidiaries and Affiliates0.00
Proceeds from Sales of Business, Affiliate and Productive Assets0.00
Accounts payable0.00
Receivables0.00
Proceeds from Life Insurance Policies0.00
Other Net-3.38
Discontinued operations0.00
Net Cash Flow from Investing Activities-2.23
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-1.71
Long-term debt - borrowings48.00
Long-term debt - repayments-63.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-12.43
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.25
Settlement Of Warrants-
Proceeds From Sale Of Note Hedge Claim-
Stock Issued During Period Value New Issues-
Payments of Ordinary Dividends, Noncontrolling Interest0.00
Dividends paid-1.87
Net Cash Flow from Financing Activities-31.26
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow28.84
Total Cash Flow3.55
4 historic quarters locked

Sign in to unlock the full Core Laboratories Inc cash flow history.

Sign In Create Free Account

About Core Laboratories Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 20, 2026
  • Source: clb-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-118177

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License